Israel Englander Amphastar Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 259,650 shares of AMPH stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

259,650

Previous 738,748 64.85%

Holding current value

$10.2 Million

Previous $29.5 Million 57.36%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $17.7 Million - $24 Million	-479,098 Reduced 64.85%	259,650 $12.6 Million
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $13.1 Million - $14.7 Million	338,653 Added 84.64%	738,748 $29.5 Million
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $8.36 Million - $12.4 Million	195,078 Added 95.15%	400,095 $17.6 Million
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $1.03 Million - $1.46 Million	-23,213 Reduced 10.17%	205,017 $12.7 Million
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $4.13 Million - $6.73 Million	-115,330 Reduced 33.57%	228,230 $13.1 Million
Q1 2023 May 15, 2023	BUY	$27.99 - $37.92 $6.89 Million - $9.33 Million	246,130 Added 252.62%	343,560 $12.9 Million
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $2.34 Million - $2.62 Million	83,670 Added 608.07%	97,430 $2.73 Million
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $1.88 Million - $2.58 Million	-68,281 Reduced 83.23%	13,760 $387,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $2.72 Million - $3.86 Million	-91,280 Reduced 52.67%	82,041 $2.85 Million
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $2.3 Million - $3.65 Million	100,140 Added 136.84%	173,321 $6.22 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $2.24 Million - $2.88 Million	-123,757 Reduced 62.84%	73,181 $1.7 Million
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $3.22 Million - $3.88 Million	180,428 Added 1092.84%	196,938 $3.74 Million
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $1.77 Million - $2.16 Million	-103,185 Reduced 86.21%	16,510 $333,000
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $1.03 Million - $1.24 Million	-59,998 Reduced 33.39%	119,695 $2.19 Million
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $927,569 - $1.11 Million	52,228 Added 40.97%	179,693 $3.61 Million
Q3 2020 Nov 16, 2020	BUY	$17.99 - $22.22 $1.5 Million - $1.86 Million	83,631 Added 190.79%	127,465 $2.39 Million
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $624,634 - $984,511	43,834 New	43,834 $985,000
Q4 2019 Feb 14, 2020	SELL	$17.07 - $20.64 $924,852 - $1.12 Million	-54,180 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $753,117 - $890,979	39,389 Added 266.3%	54,180 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $108,714 - $131,928	-5,746 Reduced 27.98%	14,791 $312,000
Q1 2019 May 14, 2019	SELL	$19.46 - $25.28 $2.33 Million - $3.03 Million	-119,970 Reduced 85.38%	20,537 $420,000
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $992,337 - $1.26 Million	56,001 Added 66.27%	140,507 $2.8 Million
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $707,724 - $891,208	45,986 Added 119.38%	84,506 $1.63 Million
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $74,700 - $100,077	-5,106 Reduced 11.7%	38,520 $588,000
Q1 2018 May 15, 2018	SELL	$17.23 - $20.35 $4.31 Million - $5.09 Million	-250,046 Reduced 85.14%	43,626 $818,000
Q4 2017 Feb 14, 2018	BUY	$17.76 - $19.75 $4.93 Million - $5.49 Million	277,771 Added 1746.88%	293,672 $5.65 Million
Q3 2017 Nov 14, 2017	BUY	$14.73 - $17.99 $234,221 - $286,058	15,901	15,901 $284,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account